Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Maternal serum placental growth factor and soluble fms-like tyrosine kinase 1 as early predictors of preeclampsia.

Shokry M, Bedaiwy MA, Fathalla MM, Alsemary A, Elwakil S, Murphy A.

Acta Obstet Gynecol Scand. 2010;89(1):143-6. doi: 10.3109/00016340903289892.

PMID:
20021269
2.

[Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester].

Ye YH, Liu L, Zhan Y, Peng W.

Zhonghua Fu Chan Ke Za Zhi. 2006 Jul;41(7):433-5. Chinese.

PMID:
17083803
3.

Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.

Khalil A, Maiz N, Garcia-Mandujano R, Penco JM, Nicolaides KH.

Ultrasound Obstet Gynecol. 2016 Mar;47(3):324-31. doi: 10.1002/uog.15750. Epub 2016 Jan 26.

4.

Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF.

Krysiak O, Bretschneider A, Zhong E, Webb J, Hopp H, Verlohren S, Fuhr N, Lanowska M, Nonnenmacher A, Vetter R, Jankowski J, Paul M, Schönfelder G.

Circ Res. 2005 Dec 9;97(12):1253-61. Epub 2005 Nov 3.

5.

Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia.

Powers RW, Roberts JM, Cooper KM, Gallaher MJ, Frank MP, Harger GF, Ness RB.

Am J Obstet Gynecol. 2005 Jul;193(1):185-91.

PMID:
16021077
6.
7.

Elevated serum soluble fms-like tyrosine kinase 1 (sFlt1) level in women with hydatidiform mole.

Koga K, Osuga Y, Tajima T, Hirota Y, Igarashi T, Fujii T, Yano T, Taketani Y.

Fertil Steril. 2010 Jun;94(1):305-8. doi: 10.1016/j.fertnstert.2009.02.015. Epub 2009 Mar 9.

PMID:
19269632
8.

Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.

Buhimschi CS, Norwitz ER, Funai E, Richman S, Guller S, Lockwood CJ, Buhimschi IA.

Am J Obstet Gynecol. 2005 Mar;192(3):734-41.

PMID:
15746665
9.

Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.

Rajakumar A, Michael HM, Rajakumar PA, Shibata E, Hubel CA, Karumanchi SA, Thadhani R, Wolf M, Harger G, Markovic N.

Placenta. 2005 Aug;26(7):563-73.

PMID:
15993706
10.

The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients.

Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, Calda P, Holzgreve W, Galindo A, Engels T, Denk B, Stepan H.

Am J Obstet Gynecol. 2012 Jan;206(1):58.e1-8. doi: 10.1016/j.ajog.2011.07.037. Epub 2011 Jul 30.

PMID:
22000672
11.

An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia.

Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, Pape J, Dudenhausen JW, Denk B, Stepan H.

Am J Obstet Gynecol. 2010 Feb;202(2):161.e1-161.e11. doi: 10.1016/j.ajog.2009.09.016. Epub 2009 Oct 21.

PMID:
19850276
12.

[Alteration and potential role of soluble fms-like tyrosine kinase receptor 1 in preeclampsia].

Li Y, Li DH, Yao YQ, Min BH, Zhang CL, Hou XH, Huang L, Zhao HX.

Zhonghua Fu Chan Ke Za Zhi. 2005 Sep;40(9):581-4. Chinese.

PMID:
16202309
13.

Prediction of pre-eclampsia during early pregnancy in primiparas with soluble fms-like tyrosine kinase-1 and placental growth factor.

Rohra DK, Zeb A, Qureishi RN, Azam SI, Khan NB, Zuberi HS, Sikandar R.

Natl Med J India. 2012 Mar-Apr;25(2):68-73.

PMID:
22686711
14.

[Expression and significance of soluble fms-like tyrosine kinase 1 in preeclampsia placenta].

Ye YH, Liu L, Zhan Y, Peng W.

Zhonghua Fu Chan Ke Za Zhi. 2006 Aug;41(8):521-4. Chinese.

PMID:
17083834
15.

First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.

Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, Ecker J, Karumanchi SA.

J Clin Endocrinol Metab. 2004 Feb;89(2):770-5.

PMID:
14764795
16.

The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio.

Buhimschi CS, Baumbusch MA, Dulay AT, Lee S, Wehrum M, Zhao G, Bahtiyar MO, Pettker CM, Ali UA, Funai EF, Buhimschi IA.

BJOG. 2010 Feb;117(3):321-30. doi: 10.1111/j.1471-0528.2009.02434.x. Epub 2009 Nov 26.

17.

[Predictive value of the sFlt1/PlGF ratio for the diagnosis of preeclampsia in high-risk patients].

Husse S, Gottschlich A, Schrey S, Stepan H, Hoffmann J.

Z Geburtshilfe Neonatol. 2014 Feb;218(1):34-41. doi: 10.1055/s-0034-1368713. Epub 2014 Mar 4. German.

PMID:
24595913
18.

Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia.

Papadopoulou E, Sifakis S, Giahnakis E, Fragouli Y, Karkavitsas N, Koumantakis E, Kalmanti M.

Growth Horm IGF Res. 2006 Oct-Dec;16(5-6):290-6. Epub 2006 Sep 25.

PMID:
16996762
19.
20.

[PlGF and sFlt-1--diagnostic significance in preeclampsia prediction in pregnant women with gestational and chronic hypertension].

Manolov V, Marinov B, Vasilev V.

Akush Ginekol (Sofiia). 2013;52 Suppl 1:61-9. Bulgarian.

PMID:
24294749

Supplemental Content

Support Center